Cited by 10Metabolism, Diabetes, and CancerPhysical Activity and HealthCardiovascular and exercise physiology

Do diabetes and obesity affect the metabolic response to exercise?

Open access
Plomgaard, Peter, Weigert, Cora·2017·Current Opinion in Clinical Nutrition & Metabolic Care

Abstract

PURPOSE OF REVIEW: Exercise is recommended as therapeutic intervention for people at risk to develop type 2 diabetes to prevent or treat the disease. Recent studies on the influence of obesity and type 2 diabetes on the outcome of exercise programs are discussed. RECENT FINDINGS: Poor glycemic control before an intervention can be a risk factor of reduced therapeutic benefit from exercise. But the acute metabolic response to exercise and the transcriptional profile of the working muscle is similar in healthy controls and type 2 diabetic patients, including but not limited to intact activation of skeletal muscle AMP-activated kinase signaling, glucose uptake and expression of peroxisome proliferator-activated receptor gamma coactivator 1α. The increase in plasma acylcarnitines during exercise is not influenced by type 2 diabetes or obesity. The hepatic response to exercise is dependent on the glucagon/insulin ratio and the exercise-induced increase in hepatokines such as fibroblast growth factor 21 and follistatin is impaired in type 2 diabetes and obesity, but consequences for the benefit from exercise are unknown yet. SUMMARY: Severe metabolic dysregulation can reduce the benefit from exercise, but the intact response of key metabolic regulators in exercising skeletal muscle of diabetic patients demonstrates the effectiveness of exercise programs to treat the disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/mco.0000000000000379

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Clinical studies in patients with insulin resistant conditions have described dampened upregulation of exercise-induced factors such as FGF21 and follistatin, most likely due to an altered glucagon-to-insulin ratio.

    “Clinical studies in patients with insulin resistant conditions have described dampened upregulation of exercise-induced factors, such as FGF21 and follistatin, most likely due to an altered glucagon-to-insulin ratio [156,157,280]”

    From The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review (2020) · cites this paper as [280]

    The 'Effect on exercise-regulated hepatokines' section (p. 9) reports reduced exercise-induced follistatin secretion and blunted FGF21 secretion in type 2 diabetes, as well as an impaired FGF21 increase in obesity. It says both hepatokines are regulated by the glucagon-to-insulin ratio, but describes the cause of the impaired response as uncertain; 'most likely due to' states the mechanism more strongly than the source does. (LLM, conf=0.83)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 38 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Plomgaard, P., & Weigert, C.
Affiliations
  • Copenhagen University Hospital (DK)
  • Helmholtz Munich (DE)
Corresponding author
Weigert, Cora
Venue
Current Opinion in Clinical Nutrition & Metabolic Care
Published
2017-07
Volume
20
Issue
4
Pages
294-299
ISSN
1363-1950 (ISSN-L)
OpenAlex
W2604763813
Cited by
10
References
38
Citations by year
2025: 1 · 2023: 2 · 2022: 2 · 2020: 1 · 2019: 4
FWCI
0.13
Type
journal article
Language
en
Licence
other-oa
Locations
  • Current Opinion in Clinical Nutrition & Metabolic Care (publishedVersion)
  • PubMed (publishedVersion)
  • Site cant be reached (submittedVersion, other-oa)
  • PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Physiology › Physical Activity and Health
  • Health Sciences › Medicine › Complementary and alternative medicine › Cardiovascular and exercise physiology
Keywords
type 2 diabetes, obesity, exercise metabolism, glycemic control, AMPK, skeletal muscle glucose uptake, PPARγ coactivator-1α, acylcarnitines, glucagon/insulin ratio, FGF21, follistatin, hepatokines, exercise therapy
MeSH terms
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Blood Glucose, Carnitine, Diabetes Mellitus, Type 2, Fatty Acids, Glucose, Glycogen, Humans, Liver, Obesity, Oxidation-Reduction, Signal Transduction, Exercise, Muscle, Skeletal, AMP-Activated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review